Plazomicin
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
Molecular Identity
Plazomicin
(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamide
PubChem CID: 42613186
2D Structure
Properties
C25H48N6O10
Molecular Formula
592.70
Molecular Weight
g/mol
592.3432
Exact Mass
Da
-6.2
XLogP
Drug-like (Lipinski: < 5)
269
TPSA
May have limited oral absorption
11
H-Bond Donors
15
H-Bond Acceptors
873
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
Plazomicin1154757-24-0ACHN-490plazomicinaplazomicineLYO9XZ250JACHN490(2S)-4-amino-N-[(1R,2S,3S,4R,5S)-5-amino-4-[[(2S,3R)-3-amino-6-[(2-hydroxyethylamino)methyl]-3,4-dihydro-2H-pyran-2-yl]oxy]-2-[(2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl]oxy-3-hydroxycyclohexyl]-2-hydroxybutanamideDTXSID001031303plazomicinum(2S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-((2-hydroxyethylamino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methylamino)oxan-2-yl)oxy-3-hydroxycyclohexyl)-2-hydroxybutanamideZemdri (plazomicin)RefChem:57056J01GB14DTXCID901516308
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Plazomicin
Loading drug network...